← Back to headlines
Royalty Pharma and J&J Partner on $500M R&D for Autoimmune Treatment
Royalty Pharma has entered into a $500 million research and development funding collaboration with Johnson & Johnson, specifically partnering to develop new treatments for autoimmune diseases.
30 Mar, 11:45 — 30 Mar, 11:45
Sources
Showing 1 of 2 sources
Coverage Timeline
First report: seeking-alpha · 30 Mar, 11:45|Full coverage: 2 · 1h|Window: 1h
Left-leaningCenterRight-leaning
